Pharmaceutical Product Supply – Ciprofloxacin HCl in Dextrose

The contract entails the manufacture and supply of 1,000 packages of Ciprofloxacin Hydrochloride in Dextrose, identified by NSN 6505013366179, adhering strictly to United States Pharmacopeia standards, current Good Manufacturing Practices, and all Defense Logistics Agency requirements. The product is intended for military and government use, with full compliance ensured across quality, labeling, packaging, and documentation to meet rigorous federal pharmaceutical guidelines. The work falls under NAICS code 325412, indicating pharmaceutical and medicine manufacturing. This is a subcontract issued by the Department of Defense through the Defense Logistics Agency, with a posted date of July 21, 2026, and a direct reference to contract SPE2DX25D9900 and delivery order SPE2DP26F7882. The place of performance and specific delivery location are not detailed, but the product must be delivered in accordance with DLA logistics protocols. There is no set-aside designation applied, and the contract does not specify a point of contact, suggesting administrative details are handled internally through existing DLA channels. The supplier must ensure end-to-end traceability, regulatory compliance, and timely fulfillment to support operational medical needs.